Veracyte (VCYT)
(Delayed Data from NSDQ)
$29.97 USD
+2.92 (10.79%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $29.95 -0.02 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Brokerage Reports
Veracyte, Inc. [VCYT]
Reports for Purchase
Showing records 21 - 40 ( 44 total )
Company: Veracyte, Inc.
Industry: Medical - Instruments
3Q22 - Clinical Evidence Driving Revenue Momentum
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Gaining Clarity with 2Q Volume/ Decipher Comparisons
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Continued Return to Growth and Upbeat Outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Decipher and Molecular Dx Clarity with 3Q
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
ASCO Annual Meeting: Compelling Picture of Molecular Diagnostic Future
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Too Much Transition News; Valuation Becoming Interesting
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Diverse Molecular Diagnostic Portfolio Gaining Momentum
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Healthcare 2021 Outlook: From Lab to Clinic To Patient the Transformation of Healthcare Continues
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department